Having trouble accessing articles? Reset your cache.

Biotech diversity is still lacking, BIO finds

In a report released Thursday, BIO detailed the results of its inaugural diversity survey that found biotech boards and C-suites are still overwhelmingly white and male, which in turn can make it harder for companies to hire a diverse team.

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers